BAYRY News and Press, Bayer AG ADR From 10/05/23

2023-10-05 12:10:43 ET More on Bayer Bayer: Undervalued With Clear Catalysts Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand Bayer: Still A Strong Buy Despite Lowered Guidance FMC, Bayer downgraded to Neutral at Redburn Atlantic on crop-...

2023-09-27 06:00:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood stocks have captivated investors for years now. Wood is a popular money manager because her investing style isn’t so different from many small retail investors. She...

2023-09-25 11:44:31 ET More on FMC, Bayer, Corteva FMC Corp.: Great Value Buy With 10% Dividend Growth FMC Corporation: Temporary Depressed Revenue Is A Buying Opportunity FMC Corp. falls amid new short call from Blue Orca Research (update) FMC Corp. started ...

2023-09-20 10:21:15 ET More on Bayer Seeking Alpha's Quant Rating on Bayer Historical earnings data for Bayer Dividend scorecard for Bayer Financial information for Bayer Bayer: Undervalued With Clear Catalysts For further details see: EU ...

2023-09-18 12:20:56 ET More on Corteva Seeking Alpha’s Quant Rating on Corteva Historical earnings data for Corteva Dividend scorecard for Corteva Financial information for Corteva Corteva, Inc. ( CTVA ) CEO Chuck Magro Presents at Morgan...

2023-09-17 10:00:48 ET More on Corteva Seeking Alpha’s Quant Rating on Corteva Historical earnings data for Corteva Dividend scorecard for Corteva Financial information for Corteva Corteva, Inc. ( CTVA ) CEO Chuck Magro Presents at Morgan...

2023-09-11 11:49:04 ET Summary Bayer's stock has had a volatile performance, reaching highs and lows since December 2022, when I first wrote about this company. Both from a relative and intrinsic standpoint, Bayer seems to be severely undervalued. Bayer has both short-ter...

2023-09-07 21:05:27 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2023-09-03 12:00:00 ET More on Medicare pricing negotiations Wall Street lists potential targets for Medicare drug price negotiations Analysts rule out major industry impact from drug pricing negotiations J&J, Merck, Regeneron most exposed to Medicare drug price ...

2023-08-22 00:06:59 ET Summary Bayer reporting disappointing second quarter results with declining sales and lowered the guidance for fiscal 2023. The company is continuing to struggle and total debt increased again and management is now expecting no free cash flow in 2023. Bu...